Results 171 to 180 of about 1,825 (197)

Physiologically Based Pharmacokinetic (PBPK) Modeling of Lornoxicam: Exploration of doses for CYP2C9 Genotypes and Patients with Cirrhosis

Journal of Pharmaceutical Sciences, 2022
Yong-Bok Lee, Ji-Hun Jang
exaly  

121. Epidural Lornoxicam Administration- Innocent

Regional Anesthesia & Pain Medicine, 2008
H AKTUG, B CANDUZ, O MAVIOGLU, Y ERKIN, O YILMAZ, Y UYANIKGIL, H KORKMAZ, M BAKA   +7 more
openaire   +1 more source

Anaphylactic Paradox: Is it Lornoxicam or Neostigmin ?

2013
Kelimeler: Kolesistektomi ...
ERGÜL, Dursun Fırat, DURMAZ, Funda
openaire   +1 more source

Lornoxicam

Reactions Weekly, 2013
openaire   +1 more source

Lornoxicam-Loaded Chitosan-Decorated Nanoemulsion: Preparation and In Vitro Evaluation for Enhanced Transdermal Delivery

Polymers, 2022
Arshad Farid, Khalid Rehman Hakeem, Majid Rasool Kamli   +2 more
exaly  

Amelioration of physicochemical, pharmaceutical, and pharmacokinetic properties of lornoxicam by cocrystallization with a novel coformer

Drug Development and Industrial Pharmacy, 2021
Nadeem Irfan Bukhari, Kanwal Fatima, Amjad Hussain   +2 more
exaly  

Lornoxicam

Reactions Weekly, 2017
openaire   +1 more source

Population pharmacokinetic analysis of lornoxicam in healthy Korean males considering creatinine clearance and CYP2C9 genetic polymorphism

Journal of Pharmaceutical Investigation, 2021
Yong-Bok Lee, Ji-Hun Jang
exaly  

Lornoxicam/loproxofen

Reactions Weekly, 2014
openaire   +1 more source

Comparative pharmacokinetics of parenteral lornoxicam

European Journal of Pharmacology, 1990
P. Dittrich, S. Radhofer-Welte, S. Mayerhofer, W.R. Kukovetz, H.P. Ferber   +4 more
openaire   +1 more source